Dashboard
Manage Tickers

NTLAIntellia Therapeutics, Inc.

Nasdaq intelliatx.com


$ 24.23 $ 0.07 (0.29 %)    

Friday, 21-Jun-2024 15:59:53 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.17 $ 0.00 (0 %)
DIA $ 391.56 $ -0.73 (-0.19 %)
SPY $ 544.47 $ -0.73 (-0.13 %)
TLT $ 93.96 $ 0.00 (0 %)
GLD $ 214.79 $ -3.38 (-1.55 %)
$ 24.22
$ 24.25
$ 24.17 x 107
$ 0.00 x 0
$ 23.44 - $ 24.41
$ 19.37 - $ 46.50
2,998,355
na
2.31B
$ 1.56
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-09-2024 03-31-2024 10-Q
2 02-22-2024 12-31-2023 10-K
3 11-09-2023 09-30-2023 10-Q
4 08-03-2023 06-30-2023 10-Q
5 05-04-2023 03-31-2023 10-Q
6 02-23-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-24-2022 12-31-2021 10-K
11 11-04-2021 09-30-2021 10-Q
12 08-05-2021 06-30-2021 10-Q
13 05-06-2021 03-31-2021 10-Q
14 02-26-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-06-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 02-27-2020 12-31-2019 10-K
19 10-31-2019 09-30-2019 10-Q
20 08-01-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 02-27-2019 12-31-2018 10-K
23 10-31-2018 09-30-2018 10-Q
24 08-01-2018 06-30-2018 10-Q
25 05-01-2018 03-31-2018 10-Q
26 03-14-2018 12-31-2017 10-K
27 10-31-2017 09-30-2017 10-Q
28 08-01-2017 06-30-2017 10-Q
29 05-02-2017 03-31-2017 10-Q
30 03-14-2017 12-31-2016 10-K
31 11-01-2016 09-30-2016 10-Q
32 08-04-2016 06-30-2016 10-Q
33 06-03-2016 03-31-2016 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

rxo-alnylam-pharmaceuticals-and-other-big-stocks-moving-lower-in-mondays-pre-market-session
RXO, Alnylam Pharmaceuticals And Other Big...
06/24/2024 11:54:53

5-biotech-stocks-with-key-catalysts-this-week-merck-intellia-verona-and-more
5 Biotech Stocks With Key Catalysts This W...
06/24/2024 08:51:47

Biotech investing is risk-fraught but the returns could be staggering if one chooses to take the educated approach.

cantor-fitzgerald-reiterates-overweight-on-intellia-therapeutics-maintains-65-price-target
Cantor Fitzgerald Reiterates Overweight on...
06/18/2024 14:12:26

Cantor Fitzgerald analyst Rick Bienkowski reiterates Intellia Therapeutics (NASDAQ:NTLA) with a Overweight and maintains $65...

intellia-therapeutics-announced-the-acceptance-of-an-abstract-featuring-redosing-data-from-the-phase-1-study-of-ntla-2001-has-been-selected-for-an-oral-presentation-at-the-peripheral-nerve-society-annual-meeting
Intellia Therapeutics Announced The Accept...
06/17/2024 11:33:16

NTLA-2001 is an investigational in vivo CRISPR-based gene editing therapy designed to be a single-dose treatment for transthyre...

avidity-biosciences-and-cleanspark-were-among-the-10-biggest-mid-cap-stock-gainers-last-week-june-9-june-15-are-these-in-your-portfolio
Avidity Biosciences And CleanSpark Were Am...
06/16/2024 18:25:10

Top mid-cap performers: Avidity Biosciences, Iris Energy, Hims & Hers Health, John Wiley & Sons, Element Solutions, Cle...

cathie-wood-lead-ark-invest-dumps-76m-worth-of-robinhood-shares-amid-gamestop-buzz-bitcoin-choppiness
Cathie Wood-Lead Ark Invest Dumps $7.6M Wo...
06/11/2024 02:28:34

On Monday, Cathie Wood-led Ark Invest made a significant move by reducing its holdings in Robinhood Markets Inc (NASDAQ:HOOD). ...

cathie-wood-led-ark-invest-buys-99m-worth-of-amazon-shares-also-picks-up-reddit-stock
Cathie Wood-Led Ark Invest Buys $9.9M Wort...
06/07/2024 02:25:44

cracking-the-code-understanding-analyst-reviews-for-intellia-therapeutics
Cracking The Code: Understanding Analyst R...
06/04/2024 20:00:55

cantor-fitzgerald-reiterates-overweight-on-intellia-therapeutics-maintains-65-price-target
Cantor Fitzgerald Reiterates Overweight on...
06/04/2024 17:28:53

Cantor Fitzgerald analyst Rick Bienkowski reiterates Intellia Therapeutics (NASDAQ:NTLA) with a Overweight and maintains $65...

why-intellia-therapeutics-shares-are-trading-higher-monday
Why Intellia Therapeutics Shares Are Tradi...
06/03/2024 15:33:43

Intellia's NTLA-2002 is an experimental CRISPR based gene-editing therapy being developed as a one-time treatment for hered...

stericycle-marinemax-agios-pharmaceuticals-and-other-big-stocks-moving-higher-on-monday
Stericycle, MarineMax, Agios Pharmaceutica...
06/03/2024 14:39:44

Core News & Articles
Market-Moving News for June 3rd
06/03/2024 12:35:14

GME: 103% | 'Roaring Kitty' Reveals Massive GME Position On Reddit, Including $65M Call Options: Is He Bringing 'Co...

intellia-therapeutics-announced-single-dose-of-ntla-2002-led-to-a-98-mean-reduction-in-monthly-hereditary-angioedema-attack-rate-with-an-average-follow-up-of-over-20-months-across-all-patients
Intellia Therapeutics Announced Single Dos...
06/02/2024 14:38:47

Intellia Therapeutics, Inc. (NASDAQ:NTLA), a leading clinical-stage genome editing company focused on revolutionizing medicine ...

cathie-wood-led-ark-invest-sells-nearly-28m-worth-of-robinhood-shares-amid-crypto-api-launch-and-lackluster-bitcoin-price-action
Cathie Wood-Led Ark Invest Sells Nearly $2...
05/31/2024 03:38:32

On Thursday, Cathie Wood-led Ark Invest made notable adjustments to its portfolio, including a significant sell-off of Robinhoo...

cathie-woods-ark-innovation-etf-sees-sharp-decline-among-top-holdings--here-are-10-largest-losers-within-arkf
Cathie Wood's Ark Innovation ETF Sees Shar...
05/28/2024 11:29:37

Cathie Wood's flagship ARK Innovation ETF has been navigating through significant losses, showcasing the challenges faced b...

citigroup-maintains-neutral-on-intellia-therapeutics-lowers-price-target-to-29
Citigroup Maintains Neutral on Intellia Th...
05/10/2024 21:34:12

Citigroup analyst David Lebowitz maintains Intellia Therapeutics (NASDAQ:NTLA) with a Neutral and lowers the price target fr...

bmo-capital-maintains-outperform-on-intellia-therapeutics-raises-price-target-to-70
BMO Capital Maintains Outperform on Intell...
05/10/2024 15:07:51

BMO Capital analyst Kostas Biliouris maintains Intellia Therapeutics (NASDAQ:NTLA) with a Outperform and raises the price ta...

intellia-therapeutics-q1-cash-cash-equivalents-and-marketable-securities-were-9534m-expected-to-provide-cash-runway-into-late-2026
Intellia Therapeutics' Q1 Cash, Cash Equiv...
05/09/2024 11:33:55

intellia-therapeutics-q1-2024-gaap-eps-112-beats-139-estimate-sales-28935m-beat-11504m-estimate
Intellia Therapeutics Q1 2024 GAAP EPS $(1...
05/09/2024 11:32:25

intellia-therapeutics-announced-the-acceptance-of-an-oral-presentation-from-the-phase-1-portion-of-the-ongoing-ntla-2002-phase-12-study-at-the-european-academy-of-allergy-and-clinical-immunology-congress-2024
Intellia Therapeutics Announced The Accept...
04/29/2024 11:31:35

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)